Active: new fund May 2025 Verified 5 Nov 2026
StoryHouse Ventures
Venture firm investing in founders from the Claremont Colleges community. Based in Sisters, OR.
- Type
- VC firm
- Location
- Sisters, Oregon, United States
- Stages
- Pre-seed, Seed, Series A, Series B
- Sectors
- Biotech, Healthtech and life sciences, Deep tech, AI, SaaS and software, B2B
- Fund size / AUM
- $50M StoryHouse Fund II (Form D offering, 2025); $71.9M gross private fund assets (Form ADV; private funds: 3, of which venture capital: 3)
- Latest fund or filing
- 13 May 2025
- Website
- www.storyhousevc.com
Contacts on file
For StoryHouse Ventures, the paid file holds: 2 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2067560/000206756025000001/
- adviserinfo.sec.gov/firm/summary/337386
- www.storyhousevc.com/
- www.storyhousevc.com/portfolio
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 71 lists
Venture capital firms in Oregon (16)Series B B2B investors in the US (27)Series B biotech investors in the US (34)Series B deep tech investors in the US (41)Series B B2B investors (46)Series A biotech investors in the US (59)Series B healthtech investors in the US (69)Series B biotech investors (73)Series A deep tech investors in the US (73)Series A B2B investors in the US (79)Pre-seed biotech investors in the US (81)Pre-seed B2B investors in the US (86)Series B SaaS investors in the US (108)Series B deep tech investors (113)Pre-seed deep tech investors in the US (114)Series B AI investors in the US (126)Pre-seed biotech investors (148)Series A biotech investors (153)Pre-seed B2B investors (155)Series A B2B investors (157)Seed biotech investors in the US (159)Series B healthtech investors (160)Series A healthtech investors in the US (164)Series B investors in the US (165)Seed B2B investors in the US (183)Series B SaaS investors (196)Series B AI investors (204)Seed deep tech investors in the US (205)Pre-seed healthtech investors in the US (225)Series A SaaS investors in the US (256)B2B venture capital firms in the US (257)Series A AI investors in the US (280)Series A deep tech investors (293)Biotech venture capital firms in the US (297)Seed biotech investors (300)Seed B2B investors (302)Pre-seed deep tech investors (316)Deep tech venture capital firms in the US (322)Series B investors (339)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed AI investors in the US (403)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)B2B investors (438)Series A SaaS investors (475)Biotech investors (484)Series A AI investors (500)Pre-seed investors in the US (549)Seed deep tech investors (555)Pre-seed SaaS investors (562)Pre-seed AI investors (633)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Deep tech investors (763)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)